A new trading day began on Tuesday, with C4 Therapeutics Inc (NASDAQ: CCCC) stock price down -6.03% from the previous day of trading, before settling in for the closing price of $4.31. CCCC’s price has ranged from $3.77 to $11.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.65% over the last five years. Meanwhile, its annual earnings per share averaged 42.88%. With a float of $56.92 million, this company’s outstanding shares have now reached $70.56 million.
The firm has a total of 145 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.78%, operating margin of -354.44%, and the pretax margin is -312.52%.
C4 Therapeutics Inc (CCCC) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of C4 Therapeutics Inc is 19.37%, while institutional ownership is 83.28%. The most recent insider transaction that took place on Nov 18 ’24, was worth 54,532. Before that another transaction happened on Oct 18 ’24, when Company’s Director proposed sale 13,000 for $6.41, making the entire transaction worth $83,321.
C4 Therapeutics Inc (CCCC) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.30% during the next five years compared to -36.05% drop over the previous five years of trading.
C4 Therapeutics Inc (NASDAQ: CCCC) Trading Performance Indicators
Here are C4 Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.70, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.57 in one year’s time.
Technical Analysis of C4 Therapeutics Inc (CCCC)
Analysing the last 5-days average volume posted by the [C4 Therapeutics Inc, CCCC], we can find that recorded value of 1.98 million was lower than the volume posted last year of 2.08 million. As of the previous 9 days, the stock’s Stochastic %D was 35.84%. Additionally, its Average True Range was 0.44.
During the past 100 days, C4 Therapeutics Inc’s (CCCC) raw stochastic average was set at 7.81%, which indicates a significant decrease from 21.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.23% in the past 14 days, which was higher than the 79.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.14, while its 200-day Moving Average is $6.07. Now, the first resistance to watch is $4.33. This is followed by the second major resistance level at $4.60. The third major resistance level sits at $4.77. If the price goes on to break the first support level at $3.88, it is likely to go to the next support level at $3.72. Now, if the price goes above the second support level, the third support stands at $3.44.
C4 Therapeutics Inc (NASDAQ: CCCC) Key Stats
With a market capitalization of 285.89 million, the company has a total of 70,589K Shares Outstanding. Currently, annual sales are 20,760 K while annual income is -132,490 K. The company’s previous quarter sales were 15,360 K while its latest quarter income was -24,670 K.
